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In the mammalian heart fibroblasts have important functional roles in both healthy
conditions and diseased states. During pathophysiological challenges, a closely related
myofibroblast cell population emerges, and can have distinct, significant roles. Recently,
it has been reported that human atrial myofibroblasts can express a Na+ current, INa.
Some of the biophysical properties and molecular features suggest that this INa is due to
expression of Nav 1.5, the same Na+ channel α subunit that generates the predominant INa
in myocytes from adult mammalian heart. In principle, expression of Nav 1.5 could give rise
to regenerative action potentials in the fibroblasts/myofibroblasts. This would suggest an
active as opposed to passive role for fibroblasts/myofibroblasts in both the “trigger” and
the “substrate” components of cardiac rhythm disturbances. Our goals in this preliminary
study were: (i) to confirm and extend the electrophysiological characterization of INa in a
human atrial fibroblast/myofibroblast cell population maintained in conventional 2-D tissue
culture; (ii) to identify key molecular properties of the α and β subunits of these Na+
channel(s); (iii) to define the biophysical and pharmacological properties of this INa; (iv)
to integrate the available multi-disciplinary data, and attempt to illustrate its functional
consequences, using a mathematical model in which the human atrial myocyte is coupled
via connexins to fixed numbers of fibroblasts/myofibroblasts in a syncytial arrangement.
Our experimental findings confirm that a significant fraction (approximately 40–50%)
of these human atrial myofibroblasts can express INa. However, our data suggest that
INa may be generated by a combination of Nav 1.9, Nav 1.2, and Nav 1.5. Our results,
when complemented with mathematical modeling, provide a background for re-evaluating
pharmacological management of supraventricular rhythm disorders, e.g., persistent atrial
fibrillation.
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INTRODUCTION
Within approximately the last 10 years, experimental results and
clinical data have established that both fibroblast and myofibrob-
last cell populations in the mammalian heart (including the adult
human) can play very important functional roles in physiolog-
ical and pathophysiological settings, respectively (Nattel, 2002;
Baudino et al., 2006; Munoz et al., 2008; Porter and Turner, 2009;
Baum and Duffy, 2011; Biernacka and Frangogiannis, 2011).
The fibroblast population, when judged in terms of cell num-
bers, is predominant in all adult mammalian hearts (cf. Baudino
et al., 2006). Until quite recently, these fibroblasts were consid-
ered to be passive. That is, they were thought to have few, if
any primary electrophysiological roles. Rather, both fibroblasts
and myofibroblasts were believed to function predominantly in
the synthesis, and degradation (homeostasis) of the extracellular
matrix, largely as a consequence of their roles in collagen produc-
tion/breakdown (Weber et al., 1993). However, this view changed
after publication of data demonstrating that both fibroblasts and
myofibroblasts have the capability of communicating (cell-to-
cell) electrically and metabolically through conventional connex-
ins within gap junctions. This connexin-mediated electrotonic
communication may also include functional interactions of these
fibroblasts/myofibroblasts with adjacent myocytes (Gaudesius
et al., 2003; Chilton et al., 2007; Zlochiver et al., 2008; Kakkar and
Lee, 2010). It is now apparent that both the fibroblast and the
myofibroblast cell populations can serve as a significant source
of paracrine substances that, when secreted, act on adjacent cells
(Powell et al., 1999; Pedrotty et al., 2009; Rohr, 2011). Both
fibroblasts and myofibroblasts can also be regulated by neuro-
transmitters, co-transmitters, peptides, and circulating hormones
(Brilla et al., 1995; Rose et al., 2007; cf. Rose and Giles, 2008).
Important early work on isolated fibroblasts also drew atten-
tion to the fact that the electrophysiological properties of these
cells can be modulated significantly by mechanical perturba-
tions, including both stretch and shear forces. Abramochkin et al.
(2014) have recently reviewed this data.
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Experimental work, based mainly on co-culture methods,
combined with simulations using mathematical models of, e.g.,
human atrial myocytes and fibroblasts, have drawn attention
to the possibility that the fibroblast cell population could
significantly modulate the electrophysiological substrate in a
number of cardiac tissues. Papers that deal specifically with
these interactions in the atria include: (Maleckar et al., 2009a;
Ashihara et al., 2012; McDowell et al., 2013) and ventri-
cles (MacCannell et al., 2007; Sachse et al., 2008; McDowell
et al., 2011) of the human heart. However, in all cases, these
interactions have been assumed to be passive; that is, to not
involve any regenerative or propagated responses that origi-
nate in the fibroblast/myofibroblast cell population (Gaudesius
et al., 2003; Maleckar et al., 2009a; McDowell et al., 2011,
2013).
Important early work on atrial rhythm disturbances by Spach
and his colleagues (Spach and Boineau, 1997) drew attention to
the ability of “microfibrosis” to alter the electrical substrate in the
atrium and thus promote arrhythmias. Spach et al. (2007) also
recognized that in the human atrium an important consequence
of aging was an increased incidence of supraventricular rhythm
disturbances with some fibrosis. Enhanced fibrosis in the setting
of healthy aging is now a well-known contributor to atrial flut-
ter/fibrillation (Nattel, 2002; Biernacka and Frangogiannis, 2011;
Diness et al., 2011; Guzadhur et al., 2012).
Recently, it has been reported that myofibroblasts derived from
explanted human right atrial tissue (the right atrial appendage)
can express measurable (and potentially functionally important)
Na+currents. Specifically, Chatelier et al. (2012) have reported
that approximately 75% of the myofibroblasts that are isolated
from the human right atrial appendage express Na+ current after
being maintained in a primary 2-D cell culture 8–12 days. They
observed that 100% of these cells expressed Na+ current after
13–17 days in culture. These investigators have also provided evi-
dence that this Na+ current is generated by the same Na+ channel
α subunit, Nav 1.5 that produces the Na+ current in the atria and
ventricles of the adult human heart.
After the properties of this Na+-selective integral membrane
protein in fibroblasts/myofibroblasts are understood more com-
pletely, a paradigm shift concerning the functional properties
of human cardiac syncytium in both health and disease may
be required. As an example, the expression of Nav 1.5 in this
cell population raises the possibility that the myofibroblast cell
population could be the source of ectopic foci. That is, this
Na+ current could provide a significant source of regenerative
inward current. In principle, the resulting depolarization could
serve both as the trigger and the substrate for supraventricular
rhythm disturbances originating in the fibroblast/myofibroblast
cell population.
The main focus of our study was to complement and extend
the Chatelier et al. (2012) findings by addressing four separate,
but related, objectives:
(i) To carry out whole-cell voltage clamp experiments and
obtain the additional data that is needed for determining the
probability that measurable Na+ currents, INa, in fact can
be recorded in single myofibroblasts from the human right
atrial appendage, in situations where these cells are isolated,
purified, and maintained in conventional 2-D culture.
(ii) To further define the functional roles of INa based on its fun-
damental biophysical properties, e.g., voltage-dependence of
activation and inactivation.
(iii) To make PCR measurements aimed at identifying mam-
malian Na+ channel α and β subunits in this myofibroblast
cell population.
(iv) To integrate and illustrate the consequences of the Chatelier
et al. (2012) findings and compare them with our results,
through implementation of current mathematical mod-
els of the human atrial myocyte action potential coupled
to a defined fibroblast/myofibroblast electrophysiological
parameter set, and then to study these interactions in silico
in selected ratios (myocytes/myofibroblasts) and coupling
configurations.
Here, we report our preliminary findings based on conventional
whole-cell voltage-clamp measurements of the electrophysiolog-
ical properties of single myofibroblasts that were isolated from
the human right atrial appendage and then placed in conven-
tional 2-D tissue culture for approximately 6 days (2–4 passages).
PCR analyses of the expression of a number of α and β subunits
of mammalian Na+ channels are also presented. Our results are
compared and contrasted with those in the original paper on this
topic (Chatelier et al., 2012). Mathematical models of the human
atrial myocyte and/or the fibroblast/myofibroblast are used to
explore and illustrate plausible functional consequences of Na+
current expression in the myofibroblast population.
Taken together, this experimental and theoretical work con-
tributes to ongoing discussions regarding possible functional
roles for Na+ current in human atrial myofibroblasts. These find-
ings also raise interesting possibilities and questions concerning
novel molecular targets in the compromised human atrium, e.g.,
during persistent atrial fibrillation (Benito et al., 2008; Biernacka
and Frangogiannis, 2011; Aguilar-Shardonofsky et al., 2012). This
class of rhythm disturbance is of importance due to its increased
incidence during the healthy aging process (Benito et al., 2008;
Aguilar-Shardonofsky et al., 2012; Guzadhur et al., 2012); and
because persistent atrial fibrillation can increase the incidence of
transient ischemic attack and/or stroke (cf. Bersohn et al., 2012).
METHODS
HUMAN RIGHT ATRIAL APPENDAGE TISSUE
Excised human atrial appendage specimens were obtained after
written consent from patients undergoing coronary artery bypass
graft surgeries at Foothills Medical Centre. Administrative
approval was granted to the Fedak Laboratory by the University
of Calgary Conjoint Health Ethics Board. After being trans-
ported to the Fedak Laboratory, each preparation was subjected
to enzymatic treatment resulting in release of atrial fibroblasts,
as described in previous papers from the Fedak Group (cf. Fedak
et al., 2012).
CELL CULTURE METHODS
At selected times, (2 days to 2 weeks), populations of these myofi-
broblasts were transferred to the Giles Laboratory where they
Frontiers in Physiology | Cardiac Electrophysiology August 2014 | Volume 5 | Article 275 | 2
Koivumäki et al. Na+ current in human atrial myofibroblasts
were maintained in conventional 2-D culture for an additional
1–2 days. As required, cells were released by enzymatic treatment
(trypsinization) and then used for electrophysiological studies on
that same day.
ISOLATION OF MYOFIBROBLAST RNA AND TARGETED PCR ANALYSES
Messenger RNA was isolated from these cultured human atrial
fibroblasts using a Qiagen RNeasy kit, and transformed into
cDNA using Qiagen Quantitect reverse transcriptase kit accord-
ing to the manufactures protocol. Real time-PCR analysis was
performed using Quantitect SYBR Green Master Mix and primer
pairs on a BioRad iCycler. Gene expression levels were calcu-
lated using the delta-delta CT method with 18s RNA serving
as the housekeeping gene. Values represent the mean ± s.e.m.
of three individual cell cultures performed in duplicate mea-
surements. The primers for the analysis of human alpha and
beta sodium channel subunits were generated at the University
of Calgary DNA lab and BLASTed against the human genome
to ensure 100% specificity against the targeted genes. To assess
the possibility that expression of neonatal isoforms of the car-
diac Na+ channel were upregulated, SCN5A, or Nav1.5, mRNA
expression measurements were separated into primers recogniz-
ing splice variants 1 and 2, and primers recognizing variants 3
through 6 (see Table 1).
ELECTROPHYSIOLOGICAL METHODS
A small piece of coverslip with adherent cells was placed in a
200μL recording chamber on the stage of an inverted micro-
scope, where it was superfused with a HEPES-buffered solution
(see below) at a rate of about 1ml/min. The temperature was
maintained at 20–22◦C.
Membrane currents were measured in single human atrial
myofibroblasts using whole-cell “patch clamp” techniques. Cells
that were isolated from their neighbors, and lacked obvious
connections to surrounding cells, were chosen for patch clamp
Table 1 | Primer sequences for PCR analyses of human atrial
myofibroblast Na+ channel complex transcripts.
Channel Gene Forward Reverse
NaV 1.1 SCN1A ctccccacaccagtctttgt tggtctgactcaggttgctg
NaV 1.2 SCN2A gccagcttatcaatcccaaa tcttctgcaatgcgttgttc
NaV 1.3 SCN3A gtagtggtgcattggccttt gcaccgagttctgagtagcc
NaV 1.4 SCN4A ttcacaggcatcttcacagc ggaaggagcgtagcacagac
NaV 1.5 SCN5A Var
1,2
cttcaccgccatttacacct tgcgtaaggctgagacattg
NaV 1.5 SCN5A Var
3,4,5,6
cttcaccgccatttacacct aagttcgaagagccgacaaa
NaV 1.6 SCN8A tggacatcctttttgccttc ctgcaggaccactgcagata
NaV 1.7 SCN9A ccacttcatccaccacctct actgcactgccttcgagaat
NaV 1.8 SCN10A tctttgcagcttcttcagca acccacacagtcggattagc
NaV 1.9 SCN11A cccagcagctgttaaaggag ctgggacagtcgtttggttt
NaVβ 1 SCN1B tgcgctatgagaatgaggtg atcttcttgacgacgctggt
NaVβ 2 SCN2B tgacccactctcttccatcc caccaggtcctctctgaagc
NaVβ 3 SCN3B ccacacacccagacttcctt tcctgcaaagatgcagtgac
NaVβ 4 SCN4B cccccacagtcttccaagta gagagcagaggagcaggcta
recordings. Patch pipettes were pulled from borosilicate capillar-
ies, and had a d.c. resistance of 4–9M when filled with pipette
solution. Recordings of membrane current were made with a
Multi-Clamp 700A amplifier (Molecular Devices; Sunnyvale, CA,
USA). At least 75% series resistance compensation was used
(series resistance <5M). When recording Na+ currents in the
absence of K+ currents, a P/4 subtraction protocol was used to
remove leak currents and reduce uncompensated capacity tran-
sient currents. Signals were digitized with a 1322A Digi-Data
acquisition system (Molecular Devices), stored on a microcom-
puter and analyzed offline with pClamp v.8. Plots and statistical
analysis were done with “Sigmaplot” (Systat Software; San Jose,
CA, USA or “Prism” Graphpad Software, La Jolla, CA, USA).
Current-voltage relations for the global transmembrane ionic
current expressed in single human atrial myofibroblasts were
obtained using a series of 200ms voltage clamp steps from −120
to +100mV (see Figure 1). For Na+ currents, a series of 100ms
steps from −50 to +40mV (see Figure 2) were applied at
0.1Hz. Steady-state inactivation of Na+ current was determined
with a two-step protocol consisting of a 500ms “conditioning”
FIGURE 1 | Whole cell patch clamp records of the predominant
transmembrane ionic currents recorded from an isolated human
atrial myofibroblast using our standard superfusion solution at
22–23◦C. The pipette solution in this experiment was “K+-rich.” (See
Methods for details of solutions and voltage-clamp protocols). The
superimposed current records in the bottom left panel are typical of the
data recorded when the voltage clamp “holding potential” (−50mV) was
set near the presumed resting membrane potential of the myofibroblast
(approximately −40mV). As shown, membrane depolarizations in the
voltage range from about +20 to 100mV resulted in a large “noisy”
outward current that is likely generated by Ca2+-activated K+ channels.
In this and most other recordings, hyperpolarization from HP −50mV
produced only very small current changes (see Chilton et al., 2007).
Note, however, that depolarizing steps did elicit (red trace) a small but
distinct transient inward current. The same records at an expanded time
scale are shown on the right. The data in the top panel were obtained in
response to the same levels of step depolarizations applied from a
holding potential of −120mV. As expected from the fundamental
biophysical properties of a voltage-dependent Na+ (or Ca2+) current this
hyperpolarized HP “unmasked” a much more prominent transient inward
current (see Results).
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FIGURE 2 | Scatter plots illustrating the significant range of values of
functional Na+ current expression in isolated human atrial
myofibroblasts (n = 19 cells). The data in the left panel summarizes these
findings as current densities, i.e., by expressing INa values (recorded in
response to depolarization to 0mV) normalized for cell (myofibroblast)
capacitance (mean ± s.e.m.; 30.8 ± 4.9 pF). The same data set is presented
in the right panel as peak INa at 0mV. Horizontal bars in both plots indicate
the median value of each distribution.
clamp step to −120mV, followed by a “test” step to −10mV.
Cell capacitance was obtained from the displacement current
transient produced by a +10mV step from the holding potential
(HP)−40mV, which was close to the apparent resting membrane
potential of these cells (see Discussion).
Analar grade chemicals (Sigma-Aldrich) were used to make all
solutions. “Standard” external solution consisted of (mM): NaCl,
140; KCl, 5; CaCl2, 2; MgCl2, 1; HEPES, 10; glucose, 5.5; man-
nitol, 15. pH was adjusted to 7.4 with NaOH. K+-rich “internal”
(pipette) solution consisted of (mM): K-aspartate, 100; KCl, 20;
MgCl2, 1; Na2ATP, 4; CaCl2, 0.85; EGTA, 5; HEPES, 10. pH was
adjusted to 7.2 with KOH. The approximate pCa of the solution
was 7.9. Cs+-rich pipette solution, used to isolate Na+ currents,
consisted of Cs-aspartate, 100; CsCl, 30; MgCl2, 1; Na2ATP, 4;
CaCl2, 0.85; EGTA, 5; HEPES, 10. pH was adjusted to 7.2 with
CsOH.
MATHEMATICAL MODELING OF THE HUMAN ATRIAL ACTION
POTENTIAL AND MYOFIBROBLAST/MYOCYTE INTERACTIONS
Mathematical modeling was done using a combination of (i) the
Koivumäki et al. model (2011) of the human atrial action poten-
tial and intracellular [Ca2+]i changes, and (ii) the “active” model
of the human atrial myofibroblast described in detail in Maleckar
et al. (2009a,b). For our simulations, the mathematical expres-
sion for the inwardly rectifying background K+ current, IK1, in
the fibroblast originally developed by MacCannell et al. (2007)
was modified. This was done so that this important non-linear
background current, and its contribution to the fibroblast rest-
ing potential could be simulated more accurately. Specifically, the
equation for IK1 in Nygren et al. (Nygren and Giles, 2000) was
used, and IK1 current density was scaled for the size (capacitance)
of the fibroblast. This adjustment required a directly related small
change in the size of the Na+/K+ pump current.
Three variants of this myofibroblast/atrial myocytemodel were
used in the simulations shown in Figures 6–8:
• Vo: the original model developed by Maleckar et al. (2009a)
with IK1 modified as described.
• V1: Vo with the addition of a Na+ current based on the
electrophysiological data shown in Figures 1–4.
• V2: Vo after Na+ current was parameterized based on the
in vitro data published by Chatelier et al. (2012), as opposed
to our data.
The illustrations in Figures 6–9 were generated by using these
myocyte/myofibroblast models, assuming connexin-mediated
electrotonic cell-to-cell communication with an assumed gap
junctional conductance of 0.5 nS. This value corresponds to the
lower end of those measured between fibroblast-myocyte pairs
in vitro (Maleckar et al., 2009a,b).
In addition to a 1:1 myocyte-myofibroblast coupling scheme,
two slightly more complex sets of starting conditions were
explored in these simulations. Either 3 or 9 myofibroblasts were
connected in series to 1 myocyte. Based on our findings that only
approximately 30–50% of the isolated myofibroblasts express a
measurable Na+ current, only approximately one third of these
myofibroblasts models were programmed to express a Na+ cur-
rent with the properties in Figures 1–4 (model variant V1).
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FIGURE 3 | Whole-cell voltage clamp records illustrating the activation
of the transient inward Na+ current in human atrial myofibroblasts. Raw
data (10 superimposed current records) elicited by 100ms depolarizing clamp
steps from −50 to +40mV are shown; the red trace indicates the current
elicited at 0mV. The voltage clamp protocol is shown in the inset. The plot in
the right-hand panel is an I–V curve. It was constructed by plotting the peak
inward current at each selected voltage clamp depolarization level. The patch
pipette solution in this experiment was Cs+-rich (Methods), to block the large
and rapidly activating IK−Ca, which obscured INa at potentials positive to
about +30mV (see Figure 1 and text in Results).
FIGURE 4 | Steady-state voltage-dependence of inactivation of INa in a
human atrial myofibroblast (same cell as in Figure 3). The superimposed
current records in the left panel were obtained in response to the
conventional two-step voltage clamp protocol that is illustrated in the inset
(500ms “conditioning” step from −120mV, “test” step to −20mV). Peak
inward INa values are plotted in the right-hand panel (continuous black curve)
vs. the conditioning or prepulse potential. These results reveal a conventional
inactivation relationship for INa in an adult mammalian myocyte with the
half-inactivation membrane potential and maximum slope at V1/2being −65
and 8.4mV, respectively. The relationship shown in red—a derived
voltage-dependent activation curve—is based on the data in Figure 2. See
Results for further, more detailed description.
RESULTS
A conventional whole-cell patch clamp method was used to
characterize the predominant transmembrane ionic currents in
these single isolated human atrial myofibroblasts. Representative
families of membrane currents are shown in Figure 1. In this
myofibroblast and in the majority of others that were studied,
voltage clamp depolarizations resulted in rapid activation of a
small outward current. Larger depolarizations (in the +60 to
+100mV range) consistently gave rise to large “noisy” trans-
membrane records, that are characteristic of Ca2+-activated K+
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currents. In contrast, hyperpolarizing clamp steps from the hold-
ing potential produced much smaller changes in transmembrane
current, similar to the pattern that has been reported in rat
ventricular fibroblasts/myofibroblasts (Chilton et al., 2005).
A main focus of this study was to determine whether transient
inward Na+ currents could be detected in these myofibroblasts.
For this reason, families of transmembrane currents were gen-
erated from two different holding potentials. After each cell was
voltage clamped near the resting potential, the holding potential
was set to −50mV, and step depolarizations lasting 100ms were
applied in 10mV increments covering the range of membrane
potentials −120mV to +100mV. As shown in the bottom row
of Figure 1, this protocol produced small but measurable tran-
sient inward currents (indicated by the red traces). To enhance the
likelihood of detecting Na+ current, and to attempt to record the
maximum transient inward Na+ current that could be generated
by each individual myofibroblast, the holding potential was then
set to −120mV. Transmembrane currents, in response to the
same levels of depolarization, were elicited. These families of
currents are shown in the top row of Figure 1. As expected
(as a consequence of the more hyperpolarized holding potential
removing inactivation), this maneuver resulted in significantly
larger transient inward currents (see red traces). This type of pro-
tocol was applied to 40 myofibroblasts in total: the data indicate
that approximately 50% of these isolated myofibroblasts express a
measurable transient inward current, when the holding potential
was −120mV (see Discussion).
In this series of experiments, it became apparent that there was
considerable variability in the expression levels of these Na+ cur-
rents. The scatterplots in Figure 2 illustrate and summarize this
variability. Note that when the transient inward Na+ current is
measured, either in terms of current density (left) in response to
a depolarization to 0mV or plotted as peak current, (right) there
is very significant heterogeneity or scatter. The average current
density at 0mV was approximately 3 pA/pF when the holding
potential was −120mV.
The raw data (left) and current-voltage relationship (right) in
Figure 3 provide useful information concerning the peak size, as
well as the activation and inactivation kinetics, and the voltage-
dependence of this peak inward current in the human atrial
myofibroblast, respectively. The family of currents shown in the
left panel of Figure 3 was obtained by applying rectangular volt-
age clamp depolarizations from a holding potential of −120mV,
as illustrated in the inset. The peak current in response to this
step-depolarization to 0mV is highlighted in red. This current
trace provides a point of reference for the summarized data
described in Figure 2.
A representative peak inward current-voltage relationship is
shown in the right panel of Figure 3. Note that this inward
current first activates at a membrane potential near −50mV,
and that it is maximal near 0mV. The positive limb of this
I–V curve could not be obtained in its entirety due to the
rapid activation of a substantial and noisy outward current
(see Figure 1) at membrane potentials positive to approximately
+50mV. Overall, this pattern of current changes closely resem-
bles families of currents and peak current-voltage relationships
that have been published for Na+ current in cardiac myocytes.
This includes myocytes from human atrium (Baba et al., 2006),
and data based on heterologous expression, when the α subunit
of the cardiac Na+ channel, Nav 1.5 is overexpressed in mam-
malian cell lines, and then studied with conventional patch clamp
methods.
The raw data and corresponding analysis shown in Figure 4
summarize our experimental measurements of the steady-state
inactivation characteristics of the Na+ current in these human
atrial myofibroblasts. A conventional two-step voltage clamp pro-
tocol was used to progressively inactivate this Na+ current. From
a holding potential of −120mV, a relatively long “inactivating”
prepulse (500ms) was applied, and this was followed immediately
by a second step-depolarization to −10mV. As expected and
as illustrated in the superimposed currents in the left panel,
when the prepulse voltage depolarized the cell beyond approxi-
mately −40mV, peak Na+ current decreased progressively. This
voltage-dependent inactivation was characterized over the entire
physiological range of membrane potentials, as shown in the plot
in the right panel of this Figure. The best-fit parameters for this
steady-state inactivation relationship were: membrane potential
for half an activation or Vh −65mV, and maximum slope factor
8.4mV. In this panel of Figure 4, the sigmoid relationship shown
in red is a derived relationship depicting voltage-dependent acti-
vation for the Na+ currents shown in Figure 3 (right).
These electrophysiological findings are somewhat similar to
those in the original paper on this topic (Chatelier et al., 2012).
Certainly, both data sets reveal the functional expression of Na+
channels in tissue cultured human atrial myofibroblasts.
Additional molecular evidence for the expression of Na+ chan-
nels in these human atrial myofibroblasts is presented in Figure 5.
These histograms are based on our PCR analyses of the relative
expression levels of a range of human Na+ channel (SCN-5) α
and β subunits. From panel A note the two strongest α subunit
signals are for the “nerve” Na+ channels SCN9A and SCN2A,
respectively. However, the predominant (TTX-insensitive) mam-
malian heart α subunit was also be detected. Figure 5B presents
analogous PCR data directed toward Na+ channel β subunits.
Here, the β1 subunit represents the predominant signal (see
Discussion).
Our data (Figures 1–5) and the Chatelier et al. publication
(2012) that first reported functional expression of Na+ current
in human atrial myofibroblasts suggest the possibility that these
cells may be able to exhibit regenerative, action potential-like
responses when appropriate depolarizing stimuli are applied.
Figures 6–8 illustrate the results of in silico tests of this
possibility.
For these simulations, two quite different starting conditions
were chosen: (i) the myofibroblast was assumed to have a resting
membrane potential Em of −35mV, and (ii) the myofibroblast
Em values were set at −60mV. This was done in recognition
of the uncertainty of the fibroblast resting potential in situ
(see Discussion), and because the Na+ current is inactivated
almost completely at −35mV. In both cases, selected 16ms de-
and hyperpolarizing stimuli were applied intracellularly, as dia-
grammed in Figure 6A.
The results in Figures 6B,C illustrate the responses when
the myofibroblast was stimulated from a steady membrane
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FIGURE 5 | Histograms of normalized data from PCR measurements of
relative levels of Na+ channel α and β subunits, based on RNA derived
from populations of isolated human atrial myofibroblasts maintained
in 2-D tissue culture. Note from panel (A) the predominant α subunits are
SCN9A and SCN2A; Panel (B) shows that the strongest β subunit signal is
for β1. However, the cardiac isoform of Na+ current α subunit, SCN5A, also
can be detected (see Discussion). Sample size for mRNA measurements
are from n = 3 individual samples for plated and collagen treated fbs (only
plated values are shown). The statistical analysis was based on the
difference between plated and collagen treated cells, with a simple
unpaired t-test to compare gene expression under the two conditions.
potential of −35mV, and no INa was introduced/expressed. As
expected, the myofibroblast membrane potential responds to
small rectangular stimuli with a quasi-exponential electrotonic
de- or hyperpolarization, having characteristic time-courses gov-
erned approximately by the product of the mean input resis-
tance (3–5 Gigohms) and single cell capacitance (6–10 pF).
Note that the original mathematical model of the myofibroblast
employed in these simulations (MacCannell et al., 2007) includes
a rapidly activating delayed rectifier K+ current, in accordance
with experimental data from rat ventricular myofibroblasts. This
K+ current is activated when Em depolarizes positive to approx-
imately −30mV. Indeed, the myofibroblast exhibits a partial
repolarization (top trace, panel B) at positive membrane voltages
(approximately 0mV). In addition, a post-stimulus hyperpolar-
ization due to the subsequent deactivation of this K+ current
was observed. The results in Figure 6D,E were obtained using
the same 4 constant current stimuli (panel A) after the Na+ cur-
rent (identified in our study; Figures 1–4) was introduced. Note
(panel E) that there is a tendency for regenerative depolarization
in the voltage responses corresponding to all 3 depolarizing stim-
uli when Em is set at−65mV. The data in panels F andG is analo-
gous to that in panelsD and E, except that in these simulations INa
equations that replicate the Na+ current described by Chatelier
et al. (2012) have been “introduced” into the myofibroblast.
In the next two sets of computational studies, a mathemat-
ical model of the human atrial myocyte was combined with
the modified mammalian myofibroblast model that is described
in Methods. Three sets of computations were done: (i) a fixed
number of in silicomyofibroblasts were coupled to a single human
atrial myocyte through a linear resistance corresponding to a con-
ductance of 0.5 nS. These results are shown in the left column,
panels B,E,H of Figure 7. (ii) In the second set of computa-
tions, Na+ current consistent with the biophysical properties
depicted in Figures 1–4 in this paper was introduced into the
myofibroblast cell population. These results are shown in the
middle column, or panels C, F, and I of Figure 7. (iii) Finally,
an analogous set of computations was done, this time using
the Na+ current having the biophysical properties reported by
Chatelier et al. (2012). In Figure 7, these computations are shown
in the third column, or panels D,G,J. For a reference and start-
ing point, panel A shows the atrial myocyte resting potential and
action potential waveform (red); and also illustrates the assigned
myofibroblast resting potential when these two types of cells are
not coupled. Overall, this pattern of responses was not particu-
larly revealing with respect to Na+-current dependent patterns
of action potential waveforms or the electrotonic responses in the
myofibroblast population. Specifically, the expression of Na+ cur-
rent in the myofibroblast appeared to have no significant effects
on the electrotonic waveform.
Note, however, that an important variable was that the myofi-
broblast resting membrane potential was initially set to that
reported for these isolated cells, namely approximately −35mV.
After coupling in the 1:1 (panels B–D) and 1:3 (panels E–G) cases
the fibroblast hyperpolarized and experienced a significant elec-
trotonic depolarization and repolarization driven by the myocyte
action potential. In the case of 1:9 ratio coupling (panels H–J)
the atrial myocyte depolarized significantly and exhibited only a
weak regenerative response, which resulted in a small electrotonic
depolarization in the myofibroblast(s). We note that when the
resting potential in either the myocyte or the fibroblasts is pos-
itive to approximately −60mV, INa would be strongly inactivated
(see Figure 4), and thus would not contribute to the membrane
voltage profile in the myofibroblast or the immediately adjacent
myocyte.
After recognizing that the resting membrane potential of the
myofibroblast was a critically important determinant of the size
of the peak inward Na+ current, a second set of computations
was carried out with themembrane potential of the myofibroblast
set to approximately −65mV, rather than −35mV. In Figure 8,
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FIGURE 6 | Illustration of “electrotonic” responses in an in silico human
atrial myofibroblast produced by 16ms constant current stimuli that
progressively depolarize or hyperpolarize the myofibroblast model. The
stimulus protocol is shown in panel (A). The superimposed responses in
(B,C) were obtained using a modified (see Methods) MacCannell et al. (2007)
model of an atrial myofibroblast with no Na+ current added. The families of
responses in (D,E) were obtained when this model also included equations
for the Na+ current in this paper; or the Na+ current in the Chatelier et al.
paper (2012) (F,G). Note when Na+ current is included, most of the
depolarizing stimuli produce a biphasic response. This may suggest a
contribution of Na+ current activation to the stimulus-induced depolarization
(see Discussion).
the presentation of the data is the same as that of data Figure 7.
Thus, the panels in column 1 (B,D,E,H) were based on com-
putations done with no Na+ current in the myofibroblast cell
population, and with coupling ratios of myocyte to myofibrob-
lasts of 1:1, 1:3, and 1:9, respectively. As expected from our
previous papers (MacCannell et al., 2007; Maleckar et al., 2009a),
the myocyte membrane potential dominates that of the myofi-
broblast at low myofibroblast/myocyte ratios. In distinction, to
when the myofibroblast resting membrane potential is much
more depolarized (−35mV), when the coupling ratio is 1:3 or
1:9, both themyofibroblasts and themyocytes have well-polarized
resting membrane potentials. Partly for this reason, the waveform
of the voltage change in the myofibroblast also differs substan-
tially. This arises from the fact that more hyperpolarized resting
membrane potential removes inactivation from the Na+ chan-
nels. This effect would be expected to be strongly manifested in
the computations shown in panels C,F,I—as well a D,G,I, since
the voltage dependence for inactivation of the Na+ current falls
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FIGURE 7 | Illustration of the effects of coupling selected numbers
of myofibroblasts to 1 human atrial myocyte using an in silico
hybrid mathematical model similar to the one first described by
Maleckar et al. (2009a) when assuming a myofibroblast resting
potential of −35 or −65mV. Panel (A) shows the human atrial
myocyte action potential (red) and the myofibroblast at a resting
potential of −35mV, prior to these cells being coupled through a linear
intercellular conductance of 0.5 nS. The remainder of this Figure is
arranged in three rows. Panels (B–D) illustrate responses obtained
when the myocyte to myofibroblast ratio is 1:1, panels (E–G) were
computed based on a myocyte to myofibroblast ratio of 1:3; and panels
(H–J) show responses when myocyte to myofibroblast ratio was 1:9.
The arrangement of the vertical columns allow a direct comparison of
the electrophysiological effects of (a) there being no Na+ current in any
myofibroblast (left column, panels B,E,H); (b) the Na+ current identified
in our laboratory and described in the paper being introduced (panels
C,F,I); or (c) the Na+ current reported by Chatelier et al. (2012) being
added to each myofibroblast (D,G,J). Note that the myocyte action
potential causes a significant electrotonic waveform in each
myofibroblast at ratios of 1:1 and 1:3. At a coupling ratio of 1:9, the
myofibroblasts exert a pronounced depolarizing influence of the myocyte
resting potential in these assumed conditions (see Discussion).
well within the range of the resting membrane potential of the
myofibroblast.
Careful inspection of some of the computational results in
Figures 7, 8 may suggest that activation of INa in the myofibrob-
last influences the overall “substrate” electrophysiological profile.
Thus, in some cases, the membrane potential in the myofibrob-
last(s) depolarizes, when the atrial myocyte is repolarizing.
The computational results shown in Figure 9 provide some
further insight into this intriguing possibility. All of these
computations were done using a 1 myocyte to 1 myofibroblast
ratio. Two different values of coupling (intercellular) resistance,
either 0.5 nS (top row) or 8 nS (bottom row) were selected for
study. As expected, when intercellular resistance is very small, the
myocyte action potential produces an electrotonic response in the
myofibroblast that is essentially unattenuated.
Note that at both these values of intercellular resistance (pan-
els C,D), the current flowing between the “cells” is dominated
by the net inward (depolarizing) and outward (repolarizing)
www.frontiersin.org August 2014 | Volume 5 | Article 275 | 9
Koivumäki et al. Na+ current in human atrial myofibroblasts
FIGURE 8 | Illustration of the effects of coupling selected numbers
of myofibroblasts to 1 human atrial myocyte using an in silico
hybrid model similar to the one first described by Maleckar
et al. (2009a), assuming a myofibroblast resting potential of
−65mV. The layout of this Figure is the same as that of Figure 7.
Note that two potentially important differences in the patterns of in
silico responses were obtained: (1) in all situations, the myofibroblast
electrotonic responses are larger, (2) the myofibroblasts exert only a
minimal depolarizing influence on the resting potential of the atrial
myocyte.
currents generated by the atrial myocyte. Panels E and F show
the net transmembrane current in the myofibroblast population.
Again, the inward, depolarizing current appears to be contributed
mainly by the activation of INa in the atrial myocyte(s), as
opposed to the myofibroblast(s) (see Discussion).
DISCUSSION
MAIN FINDINGS
The whole-cell voltage clamp measurements shown in
Figures 1–4 confirm that when human atrial fibroblasts are
isolated and then placed in conventional 2-D culture, a sizeable
fraction (approximately 50%) of these cells (myofibroblasts)
express a measurable Na+ current. A number of electrophysio-
logical and biophysical features of this current are noteworthy.
(i) Its peak amplitude (in the range: 0.8–17.9 pA/pF) is sufficient
to suggest that the myofibroblast may exhibit a regenerative
action potential. (ii) The steady-state voltage dependence of
inactivation, and the derived relationship that depicts quasi
steady-state voltage dependence of activation, both strongly
resemble the analogous biophysical parameters for the Na+
current recorded in adult human atrial myocytes (Baba et al.,
2006). (iii) These findings, in conjunction with the PCR data
in Figure 5, provide initial evidence that this current is similar
to the Na+ current in an adult human atrial myocyte, as was
originally reported by Chatelier et al. (2012). However, we note
that our PCR analysis yielded data that identifies two nerve Na+
channel α subunits, Nav1.9 and Nav1.2, as the predominant
transcripts. The cardiac Na+ channel α subunit was detectable
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FIGURE 9 | Illustration of two selected values of the effects of coupling
resistance on the electrotonic membrane potential (panels A,B), “gap
current” and current flow between the two cell populations (1 myocyte:
1 myofibroblast, panels C,D) and the net transmembrane current in the
collective myofibroblast population (panels E,F). See text in Results for
further explanation.
in our myofibroblast preparation, but was less prominent than
either Nav1.9 or Nav1.2.
Some of our findings differ from those in the original paper
(Chatelier et al., 2012) that first identified Na+ current in human
atrial myofibroblasts. One of their most striking findings was that
this Na+ current exhibited a very hyperpolarized range of mem-
brane potentials for activation and inactivation (see Figures 2B,
3A, in Chatelier et al., 2012). The reasons for these important
differences may be due to the fact that some of the experimen-
tal conditions in the two studies differ. In the Chatelier et al. work
(2012), the pH of the “internal solution” was 7.4; and perhaps
more importantly, CsF rather than CsCl was used in the pipette-
filling solution. It is well-known that F− in the internal solution
can cause a pronounced hyperpolarizing shift in Na+ current gat-
ing parameters (Chandler andMeves, 1970). An important conse-
quence of the gating variables for the Na+ current being shifted in
the hyperpolarizing direction in the Chatelier et al. paper (2012)
is that the myofibroblast resting potential would need to be nega-
tive to −60mV before this current could be activated. Second, in
principle, there could be a substantial non-inactivating or “back-
ground/steady” Na+ influx, when the myofibroblast membrane
potential is in the voltage range approximately −90 to −40mV.
This would depolarize the myofibroblast and tend to increase
[Na+]i and have significant secondary consequences on [Ca2+]i,
and [pH]i homeostasis.
These considerations raise the very important question:
what is the resting potential of the human atrial fibrob-
last/myofibroblast? Values in the range −30 to −50mV are
often reported for isolated single cell mammalian fibrob-
last/myofibroblast preparations. However, accurate measurement
of membrane potential in these small cells is very challenging
(Dubois, 2000), especially under conditions, in which a back-
ground inwardly rectifying K+ current is expressed (Wilson
et al., 2011). This is the case in cardiac fibroblasts/myofibroblasts
(Chilton et al., 2007), since an inwardly rectifying background
current is expressed. It is also useful to recall that, as it is
in fibroblasts, the classical experiments of the Kiseleva Group
(Kiseleva et al., 1998; Kamkin et al., 2002; cf. Kohl, 2003) show
that the mechano-sensitivity of cardiac fibroblasts can signifi-
cantly change membrane potential (Abramochkin et al., 2014).
It is likely that fibroblast membrane potential may vary with the
mechanoelectric activity of the heart.
As mentioned, the data from our PCR measurements differ
from the original findings (Chatelier et al., 2012) concerning the
molecular identity of the Na+ current α subunit(s) in human
atrial myofibroblasts (see Figure 6). Thus, we suggest that the
major α subunits are Nav1.9 and Nav 1.2, as opposed to Nav
1.5. Of the four known Na+ channel β subunits that could, in
principle, contribute to the Na+ channel complex (Abriel and
Kass, 2005), the β1 subunit predominates in the human atrial
myofibroblasts in themammalian heart, as is the case in the corre-
sponding adult myocyte. At present, we cannot explain the signif-
icant difference in the pattern of Na+ channel α subunit expres-
sion. However, it is possible that our cell culture preparation is less
uniform than that of Chatelier et al. (2012). Our PCR analysis was
done using a preparation that had been plated on coverslips only
24–48 h before being studied. However, these myofibroblasts had
been passaged a number of times (2–6) before they were “released
and plated.” In contrast, Chatelier et al. studied myofibroblasts
after some 3 weeks in culture, corresponding to approximately
passage 9. This difference is an important issue that can only be
resolved by a separate, much more extensive study.
Our study did not focus on the molecular pharmacology of the
Na+ currents in the myofibroblast. However, the original paper
(Chatelier et al., 2012) reported (Figure 5) that tetrodotoxin
(TTX) did block this current. In these experiments, the effective
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concentrations of TTXwere in the 10–100μMrange. This further
supports its identity as a cardiac myocyte-like Na+ current, gen-
erated by the complex of Nav 1.5 and the β1 subunit.
COMPUTATIONAL WORK
It is somewhat surprising that introduction of Na+ current into
the modified MacCannell model of the mammalian fibroblast
(MacCannell et al., 2007) did not result in any convincing action
potential-like regenerative responses (Figures 6, 7). With respect
to the results shown in Figure 6, this may be due to the fact
that the relatively depolarized “assigned” resting potential (−35
or −65mV) of the fibroblasts/myofibroblasts resulted in very sig-
nificant inactivation of INa. A second contributing factor may be
the incomplete information concerning the kinetics of activation
and inactivation of INa in the human atrial myofibroblast. The
high input resistance of these cells (5–10 Gigohms) results in a
large intrinsic membrane time constant; and this may contribute
to Na+ current “accommodation”—inactivation developing at a
rate similar to activation at membrane potential near the normal
firing threshold for INa.
At this stage of its development, the hybrid modeling illus-
trated in Figures 7, 8 does not independently reveal significant
new information. Perhaps the most realistic myocyte to myofi-
broblast ratios that we have explored is the 1:3 case. In this defined
starting condition, we confirm that the myocyte action potential
produces a significant electrotonic waveform in the connexin-
coupled myofibroblasts (MacCannell et al., 2007; Maleckar et al.,
2009a). In addition, when large differences in the resting potential
of the myofibroblast vs. the myocyte are assumed/assigned, the
myofibroblast can significantly depolarize the atrial myocyte. This
depolarization would be expected to reduce myocyte excitability
and conduction velocity; and may significantly change diastolic
Ca2+ levels. It is worth noting that these effects could be antic-
ipated to be spatially heterogeneous within the human atrial
substrate.
TRANSLATIONAL PERSPECTIVES
The expression of Na+ current (more specifically the detection of
essential components of the Na+ channel complex) in the myofi-
broblast, may be important for reasons quite different than the
well-known ability of this integral membrane protein to give rise
to a transient inward current and thus promote cell and/or sub-
strate excitability. The so-called “non-conducting functions” of
the Na+ channel complex (Kaczmarek, 2006; Brackenbury and
Isom, 2011) are gaining increasing attention, for example, in the
setting of the metastatic phase of the progression of a number of
different solid tumor cancers. During metastasis of solid tumors
and during nerve “sprouting,” it is very likely that the expression
of Na+ channels result in mechanical stability of the cells in which
they are expressed, rather than, or in addition to, a conventional
electrophysiological function (Chioni et al., 2009; Fraser et al.,
2010). Some Na+ channel β subunits can covalently link with
well-known adhesion molecules. This suggests the possibility that
expression of the β subunit, and by implication the entire Na+
complex (Abriel and Kass, 2005), may have an important adhe-
sion function. It is interesting that Watanabe et al. (2009) have
reported alterations in the β1 and β2 subunits of the Na+ channel
in tissue taken from atria that had exhibited persistent fibrillation,
a condition often associated with enhanced fibrosis and perhaps
with altered cell-matrix dynamics.
It is also known that one aspect of an acute inflammatory
response involves binding of emigrated neutrophils to the Na+
channel complex, and a resulting (very significant) Na+ influx,
due to a “late” Na+ current. This arises from Na+ channels open-
ing but then inactivating very slowly (Poon et al., 2001; Ward
et al., 2006). Thus, provided that the membrane potential of the
myofibroblast is sufficiently negative that even a small fraction
of the Na+ channels could open (see Figure 2), the pathophysi-
ological chain events involving substantial leak of Na+ into the
cell through non-inactivating Na+ channels followed by Ca2+
overload may need to be considered in the setting of cytokine or
inflammation-induced apoptosis or necrosis.
Quite recently, the so-called “re-programmed” fibroblast has
been advanced as the preparation of choice for heterologous
introduction into the compromised myocardium or other end-
organs in the context of Regenerative Medicine approaches to
Chronic Disease Management (Leri and Kajstura, 2012; Palpant
and Murry, 2012; Qian et al., 2012; Song et al., 2012; Srivastava
and Ieda, 2012; Miki et al., 2013). The fundamental principles
of fibroblast isolation and reprogramming appear now to be well
understood. However, in the cases of cardiac and vascular patho-
physiology, an essential requirement is that these implanted cells
must have a stable, quiescent electrophysiological phenotype. For
this reason, the expression of Na+ current in myofibroblast that is
the focus of this study needs to be understood fully and perhaps
avoided or suppressed. Similar considerations are likely to apply
to more preliminary attempts to use reprogrammed fibroblasts in
the context of cardiac rhythm control (Yankelson et al., 2008; Cho
and Marbán, 2010).
LIMITATIONS
A major limitation of the experimental work presented in this
paper is that, as judged by both electrophysiological and PCR
methodology, expression of Na+ channels could be detected only
a considerable time period after seeding of what were originally
human atrial fibroblasts in 2-D tissue culture. This raises the pos-
sibility (both with respect to the Chatelier paper and our work)
that Na+ channel expression could be tissue culture specific.
Such an epi-phenomenon would have little if any physiological or
pathophysiological significance. Perhaps the strongest argument
against this possibility is that, although ion channel expression
is known to change in tissue culture, under most circumstances
the expression levels are reduced (Banyasz et al., 2008). In addi-
tion, and as noted in Methods, although the enzymatic isolation
of fibroblasts from the human atrial right appendage was some-
what similar in these two studies, in fact, post-isolation treat-
ment of the resulting fibroblast/myofibroblast cell populations
differed quite significantly. In our work [consistent with the pre-
vious work and ongoing investigations in the Fedak Laboratory
(Fedak et al., 2012)], these cells are maintained and held in
a 3D-substrate for most of the post-isolation period, i.e., to
being released for study by conventional electrophysiological or
PCR methods.
The results based onmathematical modeling (Figures 6–9) are
preliminary, in part because the experimental data is incomplete.
This part of this paper is limited by a lack of information with
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respect to (i) the extent of the electrotonic coupling between
myofibroblasts, and/or (ii) among single or multi-cellular groups
of myofibroblasts and the immediately adjacent human atrial
myocytes. It would seem implausible that this coupling ratio
could be 1:1. Other, more likely possibilities are illustrated in
the computations in Figures 7 and 8. It is clear, however, that
more extensive and detailed experimental data and more refined
computations are needed to further evaluate myocyte/fibroblast
electrotonic interactions in defined starting conditions that are
directed toward a defined myocyte/fibroblast ratio.
In addition, future work will need to consider the influence
of tonic effects of autonomic transmitters and/or paracrine sub-
stances. Success based on these improvements may provide the
possibility that within the extracellular matrix of the atrium, a
“double hit” approach can be developed to modulate Na+ chan-
nel activity, and thus achieve improved anti-arrhythmic therapy
(Maingret et al., 2008).
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